American Society of Hematology

On July 13, 2017, the U.S. Senate released an updated version of the Better Care Reconciliation Act (BCRA), legislation to repeal large provisions of the Affordable Care Act (ACA).

Through a notice on its website, the Drug Enforcement Administration (DEA) recently announced significant changes to its registration renewal process. Effective January 1, 2017, the DEA is eliminating the informal grace period which the agency has previously allowed for registrants to renew their registrations. 

On December 15, 2016, the Centers for Medicare and Medicaid Services (CMS) announced the cancellation of Medicare Part B Drug Payment Model.  CMS initially proposed the demonstration on March 8, 2016 to test new models in how physician-administered drugs are paid under the Medicare program.

ASH is pleased to see the National Heart, Lung and Blood Institute’s (NHLBI) continuous support (RFA-HL-15-030) for the development of improved techniques to enhance the production of clinically relevant, functional stem cell-derived red blood cells or platelets.

Dr. Isenalumhe covers disparities in the treatment of malignant hematologic diseases of the adolescent and young adult patient population.

Dr. Terry Bishop presents a consortium of Cooperative Centers of Excellence in Hematology supported by the Division of Kidney, Urologic, and Hematologic Diseases of the National Institute of Diabetes and Digestive and Kidney Diseases.

Take the image challenge to determine what a 58-year-old man with a history of plasma cell myeloma was treated with.

Dr. Gotlib talks about fulfilling a lifelong dream of spending time with sloths by visiting Kids Saving the RainForest while on a recent trip to Costa Rica.